No risk reduction for Plasmodium vivax malaria in sickle cell disease

Hemoglobin S is known to protect against uncomplicated Plasmodium falciparum malaria. However, there is paucity of the literature regarding interaction of HbS and other malaria species. Usually, P. vivax malaria is a relapsing condition, and without radical cure with primaquine, recurrence may be ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Moiz, Bushra, Majeed, Ayesha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986039/
https://www.ncbi.nlm.nih.gov/pubmed/29881595
http://dx.doi.org/10.1002/ccr3.1507
_version_ 1783328864049561600
author Moiz, Bushra
Majeed, Ayesha
author_facet Moiz, Bushra
Majeed, Ayesha
author_sort Moiz, Bushra
collection PubMed
description Hemoglobin S is known to protect against uncomplicated Plasmodium falciparum malaria. However, there is paucity of the literature regarding interaction of HbS and other malaria species. Usually, P. vivax malaria is a relapsing condition, and without radical cure with primaquine, recurrence may be observed even with hemoglobin S.
format Online
Article
Text
id pubmed-5986039
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-59860392018-06-07 No risk reduction for Plasmodium vivax malaria in sickle cell disease Moiz, Bushra Majeed, Ayesha Clin Case Rep Clinical Images Hemoglobin S is known to protect against uncomplicated Plasmodium falciparum malaria. However, there is paucity of the literature regarding interaction of HbS and other malaria species. Usually, P. vivax malaria is a relapsing condition, and without radical cure with primaquine, recurrence may be observed even with hemoglobin S. John Wiley and Sons Inc. 2018-04-14 /pmc/articles/PMC5986039/ /pubmed/29881595 http://dx.doi.org/10.1002/ccr3.1507 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Images
Moiz, Bushra
Majeed, Ayesha
No risk reduction for Plasmodium vivax malaria in sickle cell disease
title No risk reduction for Plasmodium vivax malaria in sickle cell disease
title_full No risk reduction for Plasmodium vivax malaria in sickle cell disease
title_fullStr No risk reduction for Plasmodium vivax malaria in sickle cell disease
title_full_unstemmed No risk reduction for Plasmodium vivax malaria in sickle cell disease
title_short No risk reduction for Plasmodium vivax malaria in sickle cell disease
title_sort no risk reduction for plasmodium vivax malaria in sickle cell disease
topic Clinical Images
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986039/
https://www.ncbi.nlm.nih.gov/pubmed/29881595
http://dx.doi.org/10.1002/ccr3.1507
work_keys_str_mv AT moizbushra noriskreductionforplasmodiumvivaxmalariainsicklecelldisease
AT majeedayesha noriskreductionforplasmodiumvivaxmalariainsicklecelldisease

Ejemplares similares